TNF alpha Antikörper (AA 77-233)
Kurzübersicht für TNF alpha Antikörper (AA 77-233) (ABIN7567806)
Target
Alle TNF alpha Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 77-233
-
Verwendungszweck
- Anti-Human TNFa/TNF-alpha Monoclonal Antibody (1A062)
-
Aufreinigung
- Protein G purified from mice ascites.
-
Reinheit
- >95 %
-
Immunogen
- Mammalian cells - derived recombinant Human TNFa / TNF-alpha (Val77-Leu233).
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
-
- TNF alpha (Tumor Necrosis Factor alpha (TNF alpha))
-
Andere Bezeichnung
- TNFa
-
Hintergrund
- TNF,Tumor necrosis factor ligand superfamily member 2,N-terminal fragment,ICD2,NTF,TNF-a,TNF-alpha,Tumor necrosis factor,TNFSF2,TNFA,Cachectin,ICD1,Drug Target
-
Pathways
- NF-kappaB Signalweg, Apoptose, Caspase Kaskade in der Apoptose, TLR Signalweg, Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Positive Regulation of Endopeptidase Activity, Hepatitis C, Protein targeting to Nucleus, Inflammasome
Target
-